ClinicalTrials.gg
Drug

Celecoxib clinical trials

Also written Celebrex, SC-58635, YM 177 and Onsenal.

studies test it
383
open now
23
in phase 3
61
first study started
1998

How each study uses Celecoxib is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Celecoxib studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
31 Dec 1998 · CELEBREX · NDA 020998 (FDA, Drugs@FDA)
European Union
17 Oct 2003 · Onsenal · EMEA/H/C/000466 (EMA; now withdrawn)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Celecoxib
286
Celecoxib 200mg
14
Benzenesulfonamide, 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-
8
Celecoxib (Celebrex)
7
Celebra
5

Brand

Celebrex
132
Onsenal
4
Celebrex 200mg
2
Celebrex 100 mg
1
Celebrex 200 mg
1
celebrex 200
1
Elyxyb
1

Development codes

SC-58635
19
YM 177
12
DFN-15
1
MR308
1

Studies by the year they started

375 studies that test it; most in 2003 (46); 2 more planned to start later

Studies that test Celecoxib, by start year
YearStudies
19982
19993
20009
200115
200227
200346
200429
200519
200620
200710
200815
200913
20109
20119
20127
20137
201413
201510
201616
201710
201815
201919
20208
20217
20229
20235
20249
20257
20267

By phase

A phase 1/2 study counts in both.

Early Phase 1
8
Phase 1
69
Phase 2
167
Phase 3
61
Phase 4
77
No phase
29

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 72 · Other 311

Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (32) · National Cancer Institute (NCI) (13) · Pfizer (10) · Roswell Park Cancer Institute (7) · M.D. Anderson Cancer Center (7) · Cairo University (7) · Dana-Farber Cancer Institute (7) · University of Alabama at Birmingham (6)

Often tested with

Tested in the same studies.

Acetaminophen (19) · Gabapentin (14) · Cyclophosphamide (14) · Naproxen (11) · Capecitabine (11) · Tramadol (9) · Ketorolac (8) · Pregabalin (8)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 6

Studies that test Celecoxib.

Studies

Open first, then newest update. How each study uses Celecoxib is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 383

See all 383 studies that test Celecoxib →

Given beside what is tested · 57 — Celecoxib is usual care or a partner of the new treatment

Showing 20 of 57.

As the comparator · 53 — what is tested is compared with Celecoxib

Showing 20 of 53.

What changed recently

From the registry's own updates since Oct 18, 2026.

Codes

What other systems call Celecoxib · ClinicalTrials.gg INT006520

  • MeSH (NLM) D000068579CelecoxibConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) JCX84Q7J1LCELECOXIBConfirmed FDA, NLM, Wikidata
  • RxNorm 140587Confirmed FDA, Wikidata
  • Wikidata Q408801celecoxibConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C1728CelecoxibOne source FDA
  • DrugBank DB00482One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.